Glenmark Pharma gets USFDA nod for antiplatelet drug
newsdepo.com
Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food Drug Administration (USFDA) for Aspirin and extended-release Dipyridamole capsules in the strength of 25 mg/200 mg, the company said in a BSE filing.Glenmark Pharma gets USFDA nod for antiplatelet drug
Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food Drug Administration (USFDA) for Aspirin and extended-release Dipyridamole capsules in the strength of 25 mg/200 mg, the company said in a BSE filing. Read more